Original language | English |
---|---|
Pages (from-to) | 1442-1443 |
Number of pages | 2 |
Journal | Annals of Oncology |
Volume | 32 |
Issue number | 11 |
DOIs | |
Publication status | Published - 1 Nov 2021 |
Front-line chemo-immunotherapy is not inferior to ibrutinib in CLL
M. van Gelder*, O. Tournilhac, D. te Raa, H.P.J. Visser
*Corresponding author for this work
Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review